We have developed a complementation assay, using transiently transfected COS cells, to facilitate a molecular analysis of the herpes simplex virus type 1 glycoprotein gH. When infected by a gH-null syncytial virus, COS cells expressing wild-type gH generate infectious progeny virions and form a syncytium with neighboring cells. By deletion and point mutagenesis, we have found particular residues in the gH cytoplasmic tail to be essential for generation of a syncytium but apparently dispensable for production of infectious virions. This study emphasizes the different requirements for cell-cell and cell-envelope fusion and demonstrates that changes in the non-syn locus UL22-gH can reverse the syncytial phenotype.
Herpes simplex virus type 1 (HSV-1) infection follows fusion between the viral envelope and the cell plasma membrane (PM), or endosomal membrane. The HSV-1 envelope contains at least a dozen different membrane proteins, about 10 of which are known to be glycosylated, and virus entry is absolutely dependent on the activity of glycoproteins gB, gD, gH, and gL. The products of UL53 (gK; see reference 23), UL25, and an unknown number of other genes may also be required. HSV-1 is believed also to be capable of direct spread from cell to cell via intercellular junctions created by local fusion events between the PMs of infected and uninfected cells. More extensive cell fusion, resulting in polykaryocyte formation, occurs when cells are infected with syncytial (syn) mutants, which arise following repeated passage of virus in tissue culture (for a comprehensive overview, see reference 43) .
At least four different syn loci have been defined; UL20 (2, 30) , UL24 (24, 42) , UL53-gK (3, 22, 31, 37, 38) , and UL27-gB (7, 8, 15) . It is unclear how such mutations result in formation of syncytia; however, at least some of the UL20 and UL24 syn mutations must result in failure to express the corresponding protein. These gene products are therefore not required for cell-cell fusion but may normally serve to down regulate it. In contrast, deletion studies suggest that UL27-gB is required for cell-cell fusion, as it is for envelope-PM fusion. Syncytial alleles of UL27 generate gB proteins with an altered cytoplasmic tail (15, 20) and range from alanine-to-valine substitutions (44) to severe truncations (1) . Such amino acid substitutions or truncations presumably allow gB to participate in cell-cell fusion even in the presence of the UL20 and UL24 products. As syn mutations within UL53 are limited to missense mutations, gK, like gB, may be essential for syncytium formation.
Gene deletion and antibody inhibition studies have suggested that UL22-gH (18) and US6-gD (28, 36) are also essential for cell-cell fusion. However, no mutations conferring a syncytial phenotype have been described within either of these genes (a syn mutation initially assigned to ULl has more recently been found to reside within UL53 [29, 41] ). Thus, although there appears to be a common gB-gD-gH-gL-depen-dent apparatus for cell-cell and cell-envelope fusion, it remains unclear how fusion occurs, how it is controlled, and to what extent the various fusion-catalyzing glycoproteins contribute to regulation.
Glycoprotein H is an approximately 110-kDa protein, predicted to have an N-terminal signal sequence and a single membrane-spanning hydrophobic region close to the C terminus (6, 11, 13, 14, 18) . The amino-terminal bulk of gH is likely to reside on the outside of the cell or virus since this region contains all the consensus sites for N-linked glycosylation and all of the mutations which confer resistance to anti-gH neutralizing antibodies (16) . In this orientation, a 14-amino-acid C-terminal tail (KVLRTSVPFFWRRE in single-letter amino acid code) projects towards the cell cytoplasm or viral capsid. The external domain of gH associates with the 25-kDa glycoprotein gL (21) , and assembly of the gH-gL complex is apparently essential for cell surface trafficking and envelope incorporation of both proteins (12, 19, 39, 41) .
We have developed a transient cell expression assay to facilitate rapid molecular analysis of gH and have begun to investigate which regions of the protein are required for the various fusion events in which it participates. Surprisingly, modification of the cytoplasmic tail of gH almost completely abolishes the ability of gH to support syncytium formation by a UL27-gB syn mutant but has little effect on the yield of progeny virus or the rate at which mutant gH-containing envelopes fuse with cells.
MATERIALS AND METHODS
Viruses and cells. Vero, F6, and COS7 cells were grown in DMEM-FCS-PS: Dulbecco's modified Eagle's medium (GIBCO Laboratories) supplemented with 10% fetal calf serum (HyClone) and 1% penicillin-streptomycin (GIBCO). F6 cells are a stably transformed Vero cell line which express HSV-1 gH under the control of the HSV-1 gD promoter (13) .
HSV-1 gH-gBANG is a derivative of SC16 which carries a syn mutation in UL27 (44) (27) . Proteins were transferred to nitrocellulose at 125 mA for 1 h with a Hoefer semidry blotter and a transfer buffer identical to gel electrophoresis buffer but supplemented with 25% methanol. The filter was incubated for 1 h in blocking buffer (PBS-0.1% Tween 20-3% dried milk) and then for 2 h with a 1:2,000 dilution of rabbit anti-gH polyclonal serum (prepared as previously described [11] ) in blocking buffer and washed for 20 min with four changes of PBS-0.1% Tween 20. After incubation with peroxidase-conjugated goat anti-rabbit immunoglobulin G (Sigma) diluted 1:4,000 in blocking buffer, the filter was washed as before, treated for 1 min with enhanced chemiluminescence reagent (Amersham), and exposed to Fuji X-ray film for between 1 and 30 s.
Plasmids and UL22 mutagenesis. Plasmid pgHLmpSC11 (5) product was then used to replace the corresponding wild-type region of UL22 in SMHgH1 (Fig. 1) . In all recombinant UL22 expression plasmids, the 3' UTR was derived from the HSV-1 thymidine kinase gene rather than from UL22 itself; however, similar results were obtained for wild-type UL22 when followed by either its own 3' UTR or that of thymidine kinase (data not shown). UL22 deletions and mutations described in this study are listed in Table 1 To properly quantitate this effect, and to further investigate the properties of the mutated gH molecules, we prepared transfected-infected COS cells as before but then trypsinized them, prepared a suspension, and processed it in several ways. One aliquot was titrated onto preformed monolayers of F6 Vero cells, which provide wild-type gH in trans. Spread of even genotypically gH-virions from COS to F6 thus results in a plaque and makes it possible to count the number of COS infectious centers (ICs) (i.e., those cells which had been productively infected and transfected). Figure 3A shows that there were only slight variations (less than twofold) in the number of productively infected COS cells for each form of gH, demonstrating that each is able to mediate spread of infection from COS to F6 cells.
It was not possible to determine from the above experiment whether the mechanism or efficiency of viral spread was different for each of the forms of gH. We therefore next examined whether any of the gH mutants were defective in supporting the production of progeny virions. After seeding an aliquot of the COS cell suspension into a tissue culture dish, we allowed virus replication to proceed for 16 h and then titrated a sonicated cell extract onto F6 cell monolayers and scored plaque numbers. To take account of possible variations in the efficiency with which transfected-infected cells were recovered and replated after trypsinization, yield of progeny normalized to the number of productive cells resulting from each transfection experiment. Figure 3B demonstrates that similar yields of infectious virus were generated by each productive cell for all the forms of gH tested.
Finally, to quantitate the frequency of syncytium formation we titrated the COS suspension onto preformed Vero cell monolayers to a sufficiently low density to count the number of individual syncytia formed. The results, again normalized to numbers of productive cells, are shown in Fig. 3C . As suggested by the results of the qualitative assay, gH/SVP is greatly reduced in its ability to generate syncytia: wild-type gH and gHSVP expression supported generation of one syncytium for every three to five productively infected cells; however, only 1 in 200 gHASVP-expressing productive cells generated a clear syncytium.
Given that deletion of the SVP sequence had such a dramatic effect upon cell-cell fusion, we were surprised to observe only slight effects on virus yield (Fig. 3B) . However, a limitation of these assays was that unpenetrated virus was not inactivated at the end of the 1-h infection period; even slowly penetrating virions would therefore have eventually given rise to plaques. We reasoned that if gHASVP was defective in fusion, we might observe differences between it and gHSVP or wild-type gH by examining the rate at which mutant gHcontaining virions were able to penetrate the PM of target cells. To test this, we allowed virions containing various forms of gH to adsorb to F6 monolayers for 2 h at 4°C and then shifted them to 37°C for varying lengths of time before acid inactivation of unpenetrated virus. The results are shown in Fig. 4 . The rate of entry of virions bearing gHASVP in their envelopes is only slightly lower than that of those bearing gHSVP or wild-type gH and suggests that gHASVP is not seriously compromised in catalysis of envelope-PM fusion.
Alanine mutagenesis of the SVP sequence. Mutant proteins gHSVP and gHASVP differ in both the sequence and the length of their cytoplasmic tail. To test which of these characteristics is important for syncytium formation, we constructed plasmids to express gH mutants bearing an alanine residue in place of the residue serine, valine, or proline (Table 1) . These plasmids were transfected into COS cells and assayed as before for numbers of ICs, yield of progeny virus, rate of cell penetration, and syn-forming ability. The results are summarized in Fig. 5 . As expected, substitution of any of the three terminal residues of gHSVP by alanine has little effect upon the number of ICs generated (panel A), the normalized yield of progeny virus (panel B), or rate of penetration during infection (panel C). However, unlike gH molecules terminating with SVP, SVA, or AVP, gHSAP is severely compromised in its ability to support syncytium formation (panel D): the number of productive cells able to form a syncytium falls from at least 1 in 8 (for gHSVP) to 1 in 120 for gHSAP. Figure 6 shows a field of the syncytia resulting from attachment of transfected-infected COS cells to Vero monolayers. We conclude that the gH cytoplasmic tail residue valine 831 is important for syncytium formation, at least when residues downstream of SVP are absent.
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., * ;t * ow Why should a mutant gH molecule be much poorer at supporting one form of fusion than another? An obvious possibility is that cell-cell fusion and envelope-PM fusion require gH to perform different tasks and that these depend upon different residues in the gH tail. It is not unreasonable to suggest that these two fusion processes may have different requirements, since viral envelopes and cell surfaces differ in their degree of curvature and likely also in their lipid, cholesterol, and protein composition. It will be interesting to test whether nonsyncytial virions bearing gHASVP or gHSAP are diminished in their ability to spread directly from cell to cell (a process believed to occur by formation of limited fusion junctions between apposed PMs) or in their ability to induce polykaryocyte formation in vivo.
An alternative explanation for the observed results is that the ASVP and SAP mutations result in a generally defective or unstable gH polypeptide. There would then be insufficient active gH on the PM to allow syncytia to form but presumably enough to generate functional progeny: perhaps virions require relatively few active gH molecules in their envelopes to efficiently penetrate cell membranes. There were no apparent gross differences in the total steady-state levels of each gH polypeptide expressed in these cells, but we cannot exclude the possibility that the cell surface level of gHSAP is below some threshold critical for cell-cell fusion to occur. PM gH could also fall below this threshold level if the cytoplasmic tail mutations interfered with its intracellular trafficking, reducing the amount of gHASVP or gHSAP delivered to the cell surface. Recruitment of active gH into viral envelopes (believed to be derived from internal membranes) would be unaffected, leading to normal levels of fully infectious progeny. Although fluorescence immunocytochemistry using anti-gH antibodies suggested that all forms of gH reached the cell surface (data not shown), these studies were nonquantitative; a proper test of this possibility will require both quantitative cell-surface immunocytochemical studies and detailed examination of the rate of maturation of each recombinant form of gH. 
